Page last updated: 2024-08-23

bisantrene and Local Neoplasm Recurrence

bisantrene has been researched along with Local Neoplasm Recurrence in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crain, SM; Forastiere, AA; Garbino, C; Kasdorf, H; Perry, DJ; Tipping, SJ; Van Echo, DA1
Hahn, RG; Jones, AR; Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J1

Other Studies

2 other study(ies) available for bisantrene and Local Neoplasm Recurrence

ArticleYear
Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
    Cancer treatment reports, 1984, Volume: 68, Issue:4

    Topics: Adult; Aged; Anthracenes; Carcinoma, Squamous Cell; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local

1984
Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
    American journal of clinical oncology, 1983, Volume: 6, Issue:4

    Topics: Adenocarcinoma; Aged; Anthracenes; Antibiotics, Antineoplastic; Colonic Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rectal Neoplasms

1983